Publications by authors named "Alexis Beaulieu"

Claim this Profile
T
The tumour sink effect on Ga-PSMA-PET/CT in metastatic castration-resistant prostate cancer and its implications for PSMA-RPT: a sub-analysis of the 3TMPO study.
Atefeh Zamanian, Étienne Rousseau, François-Alexandre Buteau, Frédéric Arsenault, Alexis Beaulieu

Cancer Imaging· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly Symptomatic Progressing Cardiac Paraganglioma With Intracardiac Extension Treated With Lu-DOTATATE: A Case Report.
Alexis Huot Daneault, Mélanie Desaulniers, Jean-Mathieu Beauregard, Alexis Beaulieu, Frédéric Arsenault

Front Endocrinol (Lausanne)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer.
John Violet, Shahneen Sandhu, Amir Iravani, Justin Ferdinandus, Sue-Ping Thang, Alexis Beaulieu

J Nucl Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non-Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
Guy-Anne Turgeon, Amir Iravani, Tim Akhurst, Alexis Beaulieu, Jason W Callahan

J Nucl Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial.
Michela Del Prete, François-Alexandre Buteau, Frédéric Arsenault, Nassim Saighi, Louis-Olivier Bouchard, Alexis Beaulieu

Eur J Nucl Med Mol Imaging· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How we read FCH-PET/CT for prostate cancer.
Jean-Mathieu Beauregard, Alexis Beaulieu

Cancer Imaging· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis